BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2420900)

  • 1. Production and use of antibodies against synthetic peptides.
    Walter G
    J Immunol Methods; 1986 Apr; 88(2):149-61. PubMed ID: 2420900
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific Antibodies Reacting with SV40 Large T Antigen Mimotopes in Serum Samples of Healthy Subjects.
    Tognon M; Corallini A; Manfrini M; Taronna A; Butel JS; Pietrobon S; Trevisiol L; Bononi I; Vaccher E; Barbanti-Brodano G; Martini F; Mazzoni E
    PLoS One; 2016; 11(1):e0145720. PubMed ID: 26731525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine specificity of the murine immune response to SV40 large tumour antigen utilizing synthetic peptides that define selected epitopes.
    Bright RK; Shearer MH; Kennedy RC
    Clin Exp Immunol; 1994 Jun; 96(3):491-9. PubMed ID: 7516272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against synthetic peptides as a tool in tumor virology.
    Walter G
    Ann Sclavo Collana Monogr; 1984; 1(2):61-70. PubMed ID: 6085886
    [No Abstract]   [Full Text] [Related]  

  • 5. Structure-antigenicity relationship of peptides from the pre-S2 region of the hepatitis B virus surface antigen.
    Lee MK; Kim KL; Hahm KS; Yang KH
    Biochem Mol Biol Int; 1994 Aug; 34(1):159-68. PubMed ID: 7531533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperimmune antisera against synthetic peptides representing the glycoprotein of human immunodeficiency virus type 2 can mediate neutralization and antibody-dependent cytotoxic activity.
    Björling E; Broliden K; Bernardi D; Utter G; Thorstensson R; Chiodi F; Norrby E
    Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6082-6. PubMed ID: 2068087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of antibodies to papovavirus SV40 tumor antigen in African green monkeys.
    Rapp F; Tevethia SS; Rawls WE; Melnick JL
    Proc Soc Exp Biol Med; 1967 Jul; 125(3):794-8. PubMed ID: 15938269
    [No Abstract]   [Full Text] [Related]  

  • 8. Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.
    Marchalonis JJ; Kaymaz H; Dedeoglu F; Schluter SF; Yocum DE; Edmundson AB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3325-9. PubMed ID: 1565623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Epitope-Specific Antibodies by Immunization with Synthetic Epitope Peptide Formulated with CpG-DNA-Liposome Complex Without Carriers.
    Kim D; Lee Y; Kwon HJ
    Methods Mol Biol; 2015; 1348():127-35. PubMed ID: 26424269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural human antibodies to synthetic peptide autoantigens: correlations with age and autoimmune disease.
    Marchalonis JJ; Schluter SF; Wilson L; Yocum DE; Boyer JT; Kay MM
    Gerontology; 1993; 39(2):65-79. PubMed ID: 8514202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class II gene associations with autoantibodies to U1A and SmD1 proteins.
    Dumortier H; Abbal M; Fort M; Briand JP; Cantagrel A; Muller S
    Int Immunol; 1999 Feb; 11(2):249-57. PubMed ID: 10069423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein.
    Tainer JA; Getzoff ED; Alexander H; Houghten RA; Olson AJ; Lerner RA; Hendrickson WA
    Nature; 1984 Nov 8-14; 312(5990):127-34. PubMed ID: 6209578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic evidence that monoclonal antibodies recognize the dominant conformation of medium-sized synthetic peptides.
    Lang E; Szendrei GI; Lee VM; Otvos L
    J Immunol Methods; 1994 Mar; 170(1):103-15. PubMed ID: 7512605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of antibodies against synthetic peptides.
    Hancock DC; Evan GI
    Methods Mol Biol; 1998; 80():15-22. PubMed ID: 9664360
    [No Abstract]   [Full Text] [Related]  

  • 15. [Production and characterization of human antirenin antibodies prepared with synthetic immunogens].
    Galen FX; Evin G; Carelli C; Bouhnik J; Michel JB; Ferhentz JA; Le N'Guyen D; Seyer R; Carlson WD; Haber E
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():199-201. PubMed ID: 2461182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plasma-membrane-associated form of SV40 large tumor antigen: biochemical and biological properties.
    Butel JS; Jarvis DL
    Biochim Biophys Acta; 1986 Oct; 865(2):171-95. PubMed ID: 3021222
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51.
    Portetelle D; Dandoy C; Burny A; Zavada J; Siakkou H; Gras-Masse H; Drobecq H; Tartar A
    Virology; 1989 Mar; 169(1):34-41. PubMed ID: 2466371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of a protein using the Geysen (PEPSCAN) procedure.
    Carter JM
    Methods Mol Biol; 1994; 36():207-23. PubMed ID: 7535161
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibodies Against Mimotopes of Simian Virus 40 Large T Antigen, the Oncoprotein, in Serum Samples From Elderly Healthy Subjects.
    Mazzoni E; Guerra G; Casali MV; Pietrobon S; Bononi I; Puozzo A; Tagliapietra A; Nocini PF; Tognon M; Martini F
    J Cell Physiol; 2017 Jan; 232(1):176-81. PubMed ID: 27064510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of synthetic peptides corresponding to various epitopes of the human immunodeficiency virus envelope protein.
    Zaghouani H; Hall B; Shah H; Bona C
    Adv Exp Med Biol; 1991; 303():53-62. PubMed ID: 1725238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.